Cargando…

Lung tumour growth kinetics in SPC-c-Raf-1-BB transgenic mice assessed by longitudinal in-vivo micro-CT quantification

BACKGROUND: SPC-c-Raf-1-BxB transgenic mice develop genetically induced disseminated lung adenocarcinoma allowing examination of carcinogenesis and evaluation of novel treatment strategies. We report on assessment of lung tumour growth kinetics using a semiautomated region growing segmentation algor...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodt, Thomas, von Falck, Christian, Dettmer, Sabine, Hueper, Katja, Halter, Roman, Hoy, Ludwig, Luepke, Matthias, Borlak, Juergen, Wacker, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308131/
https://www.ncbi.nlm.nih.gov/pubmed/22348342
http://dx.doi.org/10.1186/1756-9966-31-15
_version_ 1782227400885534720
author Rodt, Thomas
von Falck, Christian
Dettmer, Sabine
Hueper, Katja
Halter, Roman
Hoy, Ludwig
Luepke, Matthias
Borlak, Juergen
Wacker, Frank
author_facet Rodt, Thomas
von Falck, Christian
Dettmer, Sabine
Hueper, Katja
Halter, Roman
Hoy, Ludwig
Luepke, Matthias
Borlak, Juergen
Wacker, Frank
author_sort Rodt, Thomas
collection PubMed
description BACKGROUND: SPC-c-Raf-1-BxB transgenic mice develop genetically induced disseminated lung adenocarcinoma allowing examination of carcinogenesis and evaluation of novel treatment strategies. We report on assessment of lung tumour growth kinetics using a semiautomated region growing segmentation algorithm. METHODS: 156 non contrast-enhanced respiratory gated micro-CT of the lungs were obtained in 12 SPC-raf transgenic (n = 9) and normal (n = 3) mice at different time points. Region-growing segmentation of the aerated lung areas was obtained as an inverse surrogate for tumour burden. Time course of segmentation volumes was assessed to demonstrate the potential of the method for follow-up studies. RESULTS: Micro-CT allowed assessment of tumour growth kinetics and semiautomated region growing enabled quantitative analysis. Significant changes of the segmented lung volumes over time could be shown (p = 0.009). Significant group differences could be detected between transgenic and normal animals for time points 8 to 13 months (p = 0.043), when marked tumour progression occurred. CONCLUSION: The presented region-growing segmentation algorithm allows in-vivo quantification of multifocal lung adenocarcinoma in SPC-raf transgenic mice. This enables the assessment of tumour load and progress for the study of carcinogenesis and the evaluation of novel treatment strategies.
format Online
Article
Text
id pubmed-3308131
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33081312012-03-21 Lung tumour growth kinetics in SPC-c-Raf-1-BB transgenic mice assessed by longitudinal in-vivo micro-CT quantification Rodt, Thomas von Falck, Christian Dettmer, Sabine Hueper, Katja Halter, Roman Hoy, Ludwig Luepke, Matthias Borlak, Juergen Wacker, Frank J Exp Clin Cancer Res Research BACKGROUND: SPC-c-Raf-1-BxB transgenic mice develop genetically induced disseminated lung adenocarcinoma allowing examination of carcinogenesis and evaluation of novel treatment strategies. We report on assessment of lung tumour growth kinetics using a semiautomated region growing segmentation algorithm. METHODS: 156 non contrast-enhanced respiratory gated micro-CT of the lungs were obtained in 12 SPC-raf transgenic (n = 9) and normal (n = 3) mice at different time points. Region-growing segmentation of the aerated lung areas was obtained as an inverse surrogate for tumour burden. Time course of segmentation volumes was assessed to demonstrate the potential of the method for follow-up studies. RESULTS: Micro-CT allowed assessment of tumour growth kinetics and semiautomated region growing enabled quantitative analysis. Significant changes of the segmented lung volumes over time could be shown (p = 0.009). Significant group differences could be detected between transgenic and normal animals for time points 8 to 13 months (p = 0.043), when marked tumour progression occurred. CONCLUSION: The presented region-growing segmentation algorithm allows in-vivo quantification of multifocal lung adenocarcinoma in SPC-raf transgenic mice. This enables the assessment of tumour load and progress for the study of carcinogenesis and the evaluation of novel treatment strategies. BioMed Central 2012-02-20 /pmc/articles/PMC3308131/ /pubmed/22348342 http://dx.doi.org/10.1186/1756-9966-31-15 Text en Copyright ©2012 Rodt et al; BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Rodt, Thomas
von Falck, Christian
Dettmer, Sabine
Hueper, Katja
Halter, Roman
Hoy, Ludwig
Luepke, Matthias
Borlak, Juergen
Wacker, Frank
Lung tumour growth kinetics in SPC-c-Raf-1-BB transgenic mice assessed by longitudinal in-vivo micro-CT quantification
title Lung tumour growth kinetics in SPC-c-Raf-1-BB transgenic mice assessed by longitudinal in-vivo micro-CT quantification
title_full Lung tumour growth kinetics in SPC-c-Raf-1-BB transgenic mice assessed by longitudinal in-vivo micro-CT quantification
title_fullStr Lung tumour growth kinetics in SPC-c-Raf-1-BB transgenic mice assessed by longitudinal in-vivo micro-CT quantification
title_full_unstemmed Lung tumour growth kinetics in SPC-c-Raf-1-BB transgenic mice assessed by longitudinal in-vivo micro-CT quantification
title_short Lung tumour growth kinetics in SPC-c-Raf-1-BB transgenic mice assessed by longitudinal in-vivo micro-CT quantification
title_sort lung tumour growth kinetics in spc-c-raf-1-bb transgenic mice assessed by longitudinal in-vivo micro-ct quantification
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308131/
https://www.ncbi.nlm.nih.gov/pubmed/22348342
http://dx.doi.org/10.1186/1756-9966-31-15
work_keys_str_mv AT rodtthomas lungtumourgrowthkineticsinspccraf1bbtransgenicmiceassessedbylongitudinalinvivomicroctquantification
AT vonfalckchristian lungtumourgrowthkineticsinspccraf1bbtransgenicmiceassessedbylongitudinalinvivomicroctquantification
AT dettmersabine lungtumourgrowthkineticsinspccraf1bbtransgenicmiceassessedbylongitudinalinvivomicroctquantification
AT hueperkatja lungtumourgrowthkineticsinspccraf1bbtransgenicmiceassessedbylongitudinalinvivomicroctquantification
AT halterroman lungtumourgrowthkineticsinspccraf1bbtransgenicmiceassessedbylongitudinalinvivomicroctquantification
AT hoyludwig lungtumourgrowthkineticsinspccraf1bbtransgenicmiceassessedbylongitudinalinvivomicroctquantification
AT luepkematthias lungtumourgrowthkineticsinspccraf1bbtransgenicmiceassessedbylongitudinalinvivomicroctquantification
AT borlakjuergen lungtumourgrowthkineticsinspccraf1bbtransgenicmiceassessedbylongitudinalinvivomicroctquantification
AT wackerfrank lungtumourgrowthkineticsinspccraf1bbtransgenicmiceassessedbylongitudinalinvivomicroctquantification